NSPR
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- InspireMD reported 30-day results from the CGUARDIANS II trial of the CGuard Prime implantJun 11, 2026
- InspireMD enrolled the first patient in the pivotal CGUARDIANS III studyJun 8, 2026
- InspireMD received FDA approval for its IDE application for the CGUARDIANS III pivotal studyMay 4, 2026
- InspireMD receives FDA approval for CGuard® Prime Carotid Stent System to prevent strokeJun 25, 2025
- InspireMD receives CE Mark for CGuard Prime EPS under EU MDR for stroke preventionJun 16, 2025